Genetics of recurrent vertigo and vestibular disorders

Current Genomics

Volumn 12, Issue 6, 2011, Pages 443-450

  Gazquez, Irene ^a   Lopez Escamez, Jose A ^a,b  

^a JUNTA DE ANDALUCÍA   (Spain)

^b HOSPITAL DE PONIENTE   (Spain)

Author keywords

Genome association studies; Meniere's disease; Recurrent vertigo; Vestibulopathies

Indexed keywords

ARTICLE; BILATERAL VESTIBULAR HYPOFUNCTION; CLINICAL FEATURE; DISEASE CLASSIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETICS; HEREDITARY ATAXIA; HUMAN; MENIERE DISEASE; MIGRAINOUS VERTIGO; PHENOTYPE; RECURRENT DISEASE; VERTIGO; VESTIBULAR DISORDER;

EID: 80052854166     PISSN: 13892029     EISSN: 18755488     Source Type: Journal    
DOI: 10.2174/138920211797248600     Document Type: Article

References (76)

1. Lopez-Escamez, J.A. Role of genomic medicine in middle and inner ear diseases. Acta Otorrinolaringol. Esp. 2011, PMID:21700264.
2. Anttila, V.; Stefansson, H.; Kallela M.;, Todt, U.; Terwindt, G.M.; Calafato, M.S.; Nyholt, D.R.;, Dimas, A.S.; Freilinger, T.; Müller Myhsok, B.; Artto, V.; Inouye, M.; Alakurtti, K.; Kaunisto, M.A.; Hämäläinen, E.; de Vries, B.; Stam, A.H.; Weller, C.M.; Heinze, A.; Heinze-Kuhn, K.; Goebel, I.; Borck, G.; Göbel, H.; Steinberg, S.; Wolf, C.; Björnsson, A.; Gudmundsson, G.; Kirchmann, M.; Hauge, A.; Werge, T.; Schoenen, J.; Eriksson, J.G.; Hagen, K.; Stovner, L.; Wichmann, H.-E.; Meitinger, T.; Alexander, M.; Moebus, S.; Schreiber, S.; Aulchenko, Y. S.; Breteler, M.M.B.; Uitterlinden, A. G.; Hofman, A.; van Duijn, C.M.; Tikka-Kleemola, P.; Vepsäläinen, S.; Lucae, S.; Tozzi, F.; Muglia, P.; Barrett, J.; Kaprio, J.; Färkkilä, M.; Peltonen, L.; Stefansson, K.; Zwart, J.A.; Ferrari, M.D.; Olesen, J.; Daly, M.; Wessman, M.; van den Maagdenberg, A.M.J.M.; Dichgans, M.; Kubisch, C.; Dermitzakis, E.T.; Frants, R.R.; Palotie, A International Headache Genetics Consortium. Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat. Genet., 2010, 42(10), 869-873.
3. Chasman, D.I.; Schürks, M.; Anttila, V.; de Vries, B.; Schminke, U.; Launer, L.J.; Terwindt, G.M.; van den Maagdenberg, A.M.J.M.; Fendrich, K.; Völzke, H.; Ernst, F.; Griffiths, L.R.; Buring, J.E.; Kallela, M.; Freilinger, T.; Kubisch, C.; Ridker, P.M.; Palotie, A.; Ferrari M.D.; Hoffmann, W.; Zee, R.Y.L.; Kurth, T. Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat. Genet., 2011, 43(7), 695-699.
4. Pessia, M.; Hanna, M.G. Episodic ataxia type 1. In: Pagon, R.A., Bird, T.D., Dolan, C., Stephens K. editors. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2010, Feb 09.
5. Imbrici, P.; D'Adamo, M.C.; Grottesi, A.; Biscarini, A.; Pessia, M. Episodic ataxia type 1 mutations affect fast inactivation of K channels by a reduction in either subunit surface expression or affinity for inactivation domain. Am. J. Physiol. Cell Physiol., 2011, Feb 9 (in press).
6. Adelman, J.P.; Bond, C.T.; Pessia, M.; Maylie, J. Episodic ataxia results from voltage-dependent potassium channels with altered functions. Neuron, 1995, 15, 1449-1454.
7. Rea, R.; Spauschus, A.; Eunson, L.H.; Hanna, M.G.; Kullmann, D.M. Variable K+ channel subunit dysfunction in inherited mutations of KCNA1. J. Physiol., 2002, 538, 5-23.
8. Zuberi, S.M.; Eunson, L.H.; Spauschus, A.; De Silva, R.; Tolmie, J.; Wood, N.W.; McWilliam, R.C.; Stephenson, J.P.; Kullmann, D.M., Hanna, M.G. A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain, 1999, 122, 817-825.
9. Eunson, L.H.; Rea, R.; Zuberi, S.M.; Youroukos, S.; Panayiotopoulos, C.P.; Liguori, R.; Avoni, P.; McWilliam, R.C.; Stephenson, J.B.; Hanna, M.G.; Kullmann, D.M.; Spauschus A. Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability. Ann. Neurol., 2000, 48, 647-656.
10. Rajakulendran, S.; Schorge, S.; Kullmann, D.M.; Hanna, M.G. Episodic ataxia type 1: a neuronal potassium channelopathy. Neurotherapeutics, 2007, 4, 258-266.
11. Griggs, R.C.; Moxley, R.T.; Lafrance, R.A.; McQuillen, J. Hereditary paroxysmal ataxia: response to acetazolamide. Neurology, 1978, 28, 1259-1264.
12. Mori, Y.; Friedrich, T.; Kim, M.S.; Mikami, A.; Nakai, J.; Ruth, P.; Bosse, E.; Hofmann, F.; Flockerzi, V.; Furuichi, T.; Mikoshiba, K.; Imoto, K.; Tanabe, T.; Numa, S. Primary structure and functional expression from complementary DNA of a brain calcium channel. Nature, 1991, 350, 398-402.
13. Guida, S.; Trettel, F.; Pagnutti, S.; Mantuano, E.; Tottene, A.; Veneziano, L.; Fellin, T.; Spadaro, M.; Stauderman, K.; Williams, M.; Volsen, S.; Ophoff, R.; Frants, R.; Jodice, C.; Frontali, M; Pietrobon, D. Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2. Am. J. Hum. Genet., 2001, 68, 759-764.
14. Jun, K; Piedras-Renteria, E.S.; Smith, S.M.; Wheeler, D.B.; Lee, T.G.; Chin, H.; Adams, M.E.; Shelller, R.H.; Tsien, R.W.; Shin, H.S. Ablation of P/Q-type Ca2+ channel currents, altered synaptic transmission, and progressive ataxia in mice lacking the alpha1Asubunit. Proc. Natl. Acad. Sci. USA, 1999, 96, 15245-15250.
15. Spacey, S.D.; Hildebrand, M.E.; Materek, L.A.; Bird, T.D.; Snutch, T.P. Functional implications of a novel EA2 mutation in the P/Qtype calcium channel. Ann. Neurol., 2004, 56, 213-220.
16. Veneziano, L.; Guida, S.; Mantuano, E.; Bernard, P.; Tarantino, P.; Boccone, L.; Hisama, F.M.; Carrera, P.; Jodice, C.; Frontali, M.; Newly characterised and 3 regions of CACNA1A gene harbour mutations associated with familial hemiplegic migraine and episodic ataxia. J. Neurol. Sci., 2009, 276, 31-37.
17. Jeng, C.J.; Sun, M.C.; Chen, Y.W.; Tang, C.Y. Dominant-negative effects of episodic ataxia type 2 mutations involve disruption of membrane trafficking of human P/Q-type Ca2+ channels. J. Cell Physiol., 2008, 214, 422-433.
18. Graves, T.D.; Imbrici, P.; Kors, E.E.; Terwindt, G.M.; Eunson, L.H.; Frants, R.R.; Haan, J.; Ferrari, M.D.; Goadsby, P.J.; Hanna, M.G.; van den Maagdenberg, A.M.; Kullmann, D.M. Premature stop codons in a facilitating EF-hand splice variant of CaV2.1 cause episodic ataxia type 2. Neurobiol. Dis., 2008, 32, 10-15.
19. Riant, F.; Mourtada, R.; Saugier-Veber, P.; Tournier-Lasserve, E. Large CACNA1A deletion in a family with episodic ataxia type 2. Arch. Neurol., 2008, 65, 817-820.
20. Labrum, R.W.; Rajakulendran, S.; Graves, T.D.; Eunson, L.H.; Bevan, R; Sweeney, M.G.; Hammans, S.R.; Tubridy, N.; Britton, T.; Carr, L.J.; Ostergaard, J.R.; Kennedy, C.R.; Al-Memar, A.; Kullmann, D.M.; Schorge, S.; Temple, K.; Davis, M.B.; Hanna, M.G. Large-scale calcium channel gene rearrangements in episodic ataxia and hemiplegic migraine: implications for diagnostic testing. J. Med. Genet., 2009, 46, 786-791.
21. Müllner, C.; Broos, L.A.M.; van den Maagdenberg, A.M.J.M.; Striessnig, J. Familial hemiplegic migraine type 1 mutations K1336E, W1684R and V1696I alter Cav2.1 Ca2+ channel gating. Evidence for α-subunit isoform-specific effects. J. Biol. Chem., 2004, 279, 51844-51850.
22. Zhuchenko, O.; Bailey, J.; Bonnen, P.; Ashizawa, T.; Stockton, D.W.; Amos, C.; Dobyns, W.B.; Subramony, S.H.; Zoghbi, H.Y.; Lee, C.C. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltagedependent calcium channel. Nat. Genet., 1997, 15, 62-69.
23. Matsuyama, Z.; Murase, M.; Shimizu, H.; Aoki, Y.; Hayashi, M.; Hozumi, I.; Inuzuka, T. A novel insertion mutation of acetazolamide- responsive episodic ataxia in a Japanese family. J. Neurol. Sci., 2003, 210, 91-93.
24. Steckley, J.L.; Ebers, G.C.; Cader, M.Z.; McLachlan, R.S. An autosomal dominant disorder with episodic ataxia, vertigo, and tinnitus. Neurology, 2001, 57, 1499-1502.
25. Cader, M.Z.; Steckley, J.L.; Dyment, D.A.; McLachlan, R.S.; Ebers, G.C. A genome-wide screen and linkage mapping for a large pedigree with episodic ataxia. Neurology, 2005, 65(1), 156-158.
26. Farmer, T.W.; Mustian, V.M. Vestibulocerebellar ataxia. A newly defined hereditary syndrome with periodic manifestations. Arch. Neurol., 1963, 8, 471-480.
27. Damji, K.F.; Allingham, R.R.; Pollock, S.C.; Small, K.; Lewis, K.E.; Stajich, J.M.; Yamaoka, L.H.; Vance, J.M.; Pericak-Vance, M.A. Periodic vestibulocerebellar ataxia, an autosomal dominant ataxia with defective smooth pursuit, is genetically distinct from other autosomal dominant ataxias. Arch. Neurol., 1996, 53(4), 338-344.
28. Escayg, A.; MacDonald, B.T.; Baulac, S.; Huberfeld, G.; An Gourfinkel, I.; Brice, A.; LeGuern, E.; Moulard, B.; Chaigne, D.; Buresi, C.; Malafosse, A. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat. Genet., 2000, 24(4), 343-345.
29. Escayg, A.; De Waard, M.; Lee D.D.; Bichet, D.; Wolf, P.; Mayer, T. Johnston, J.; Baloh, R.; Sander, T.; Meisler, M.H. Coding and noncoding variation of the human calcium-channel B4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am. J. Hum. Genet., 2000, 66, 1531-1539.
30. Jen, J.C.; Wan, J.; Palos, T.P.; Howard, B.D.; Baloh, R.W. Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology, 2005, 65(4), 529-534.
31. de Vries, B.; Mamsa, H.; Stam, A.H.; Wan, J.; Bakker, S.L.; Vanmolkot, K.R.; Haan, J.; Terwindt, G.M.; Boon, E.M.; Howard, B.D.; Frants, R.R.; Baloh, R.W.; Ferrari, M.D.; Jen, J.C.; van den Maagdenberg, A.M. Episodic ataxia associated with EAAT1 mutation C186S affecting glutamate reuptake. Arch. Neurol., 2009, 66, 97-10
32. Kerber, K.A.; Jen, J.C.; Lee, H.; Nelson, S.F.; Baloh, R.W. A new episodic ataxia syndrome with linkage to chromosome 19q13.Arch. Neurol., 2007, 64(5), 249-253.
33. Stovner, L.J.; Zwart, J.A.; Hagen, K.; Terwindt, G.M.; Pascual, J. Epidemiology of headache in Europe. Eur. J. Neurol., 2006, 13,333-345.
34. International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia, 2004, 24, Suppl 1, 9-160.
35. Lempert, T.; Neuhauser, H.; Daroff, R.B. Vertigo as a symptom of migraine. Ann. N. Y. Acad. Sci., 2009, 1164, 242-251.
36. Boycott, H.E.; Wilkinson, J.A.; Boyle, J.P.; Pearson, H.A.; Peers, C. Differential involvement of TNF alpha in hypoxic suppressionof astrocyte glutamate transporters. Glia, 2008, 56, 998-1004.
37. Dallas, M.; Boycott, H.E.; Atkinson, L.; Miller, A.; Boyle, J.P.; Pearson, H.A.; Peers, C. Hypoxia suppresses glutamate transport in astrocytes. J. Neurosci., 2007, 27(15), 3946-3955.
38. Biondi, D.M. Is migraine a neuropathic pain syndrome? Curr. Pain Headache Rep., 2006, 10, 167-178.
39. Andreou, A.P.; Goadsby, P.J. Therapeutic potential of novel glutamate receptor antagonists in migraine. Expert Opin. Investig. Drugs, 2009, 18, 789-803.
40. Baloh, R.W.; Jacobson, K.; Fife, T. Familial vestibulopathy: a new dominantly inherited syndrome. Neurology, 1994, 44, 20-25.
41. Bahmad, F.; DePalma, S.R.; Merchant S.N.; Bezerra, R.; Oliveira, C.A.; Seidman, C.E.; Seidman, J.G. Locus for familial migrainous vertigo disease maps to chromosome 5q35. Ann. Otol. Rhinol. Laryngol., 2009, 118(9), 670-676.
42. Brantberg, K. Familial early-onset progressive vestibulopathy without hearing impairment. Acta Otolaryngol., 2003, 123, 713-717.
43. Jen, J.C.; Wang, H.; Lee, H.; Sabatti, C.; Trent, R.; Hannigan, I.; Brantberg, K.; Halmagyi, G.M.; Nelson, S.F.; Baloh, R.W. Suggestive linkage to chromosome 6q in families with bilateral vestibulopathy. Neurology, 2004, 63, 2376-2379.
44. Perez-Garrigues, H.; Lopez-Escamez, J.A.; Perez, P.; Sanz, R.; Orts, M.; Marco, J.; Barona, R.; Tapia, M.C.; Aran, I.; Cenjor, C.; Perez, N.; Morera, C.; Ramirez, R. Time course of episodes of definitive vertigo in Menieres disease. Arch. Otolaryngol. Head Neck Surg., 2008, 134(11), 1149-1154.
45. Wangemann, P. Supporting sensory transduction: cochlear fluid homeostasis and the endocochlear potential. J. Physiol., 2006, 576(Pt1), 11-21.
46. Vrabec, J.T. Genetic investigations of Menieres disease. Otolaryngol. Clin. N. Am., 2010, 43(5), 1121-1132.
47. Arweiler Harbeck, D.; Horsthemke, B.; Jahnke, K.; Hennies, C. Genetic aspects of familial Meniere's disease. Otol. Neurotol., 2011 (in press)
48. Birgerson, L.; Gustavson, K.H.; Stahle, J. Familial Méniére's disease A genetic investigation. Acta Otolaryngol. (Suppl) 1984, 412, 665-70.
49. Morrison, A.W. On genetic and environmental factors in Méniére's disease. Am. J. Otol., 1994, 15(1), 35-39.
50. Bernstein, J.M.; Shanahan, T.C.; Schaffer, M. Further observations on the role of the MHC genes and certain hearing disorders. Acta Otolaryngol. (Stockh) 1996, 116, 666-671.
51. Fung, K.; Xie, Y.; Hall, S.F.; Lillicrap, D.P.; Taylor, S.A. Genetic basis of Familial Ménière's disease. J. Otolaryngol., 2002, 31(1), 1-4.
52. Morrison, A.W.; Johnson, K.J. Genetics (molecular biology) and Ménière's disease. Otolaryngol. Clin. North. Am., 2002, 35(3),497-516.
53. Frykholm, C.; Larsen, H.C.; Dahl, N.; Klar, J.; Rask-Andersen, H.; Friberg, U. Familial Ménière's disease in five generations. Otol. Neurotol., 2006, 27, 681-6.
54. Morrison, A.W.; Bailey, M.E.; Morrison, G.A. Familial Ménière's disease: clinical and genetic aspects. J. Laryngol. Otol.,2009, 123(1), 29-37.
55. Oliveira, C.A.; Messias, C.I.; Ferrari, I. Occurrence of familial Ménière's syndrome and migraine in Brasilia. Ann. Otol. Rhinol. Laryngol., 2002, 111, 229-236.
56. Klar, J.; Frykholm, C.; Friberg, U.; Dahl, N. A. Meniere's disease gene linked to chromosome 12p12.3. Am. J. Med. Genet. B Neuropsychiatr. Genet., 2006, 141B, 463-467.
57. Gabrikova, D.; Frykholm, C.; Friberg, U.; Lahsaee, S.; Entesarian, M.; Dahl, N.; Klar, J. Familiar Menierés disease restricted to 1.48 Mb on chromosome 12p12.3 by allelic and haplotype association. J. Hum. Genet., 2010, 55(12), 834-837.
58. Hietikko, E.; Kotimäki, J.; Kentala, E.; Klockars, T.; Sorri, M.; Männikkö, M. Finnish familial Meniere disease is not linked to chromosome 12p12.3, and anticipation and cosegregation with migraine are not common findings. Genet. Med., 2011, 13(5), 415-420.
59. Shearer, A.E.; DeLuca, A.P.; Hildebrand, M.S.; Taylor, K.R.; Gurrola, J. Scherer, S.; Scheetz, T.E.; Smith, R.J. Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. Proc. Natl. Acad. Sci., 2010, 107(49), 21104-21109.
60. Lynch, M.; Cameron, T.L.; Knight, M.; Kwok, T.Y.; Thomas, P.; Forrest, S.M.; Giersch, A.B.; Briggs, R.J. Pyman, B.C. Structural and mutational analysis of antiquitin as a candidate gene for Meniere disease. Am. J. Med. Genet., 2002, 110(4), 397-399.
61. Mhatre, A.N.; Jero, J.; Chiappini, I.; Bolasco, G.; Barbara, M.; Lalwani, A.K. Aquaporin-2 expression in the mammalian cochlea and investigation of its role in Meniere's disease. Hear Res., 2002, 170(1-2), 59-69.
62. Fransen, E.; Verstreken, M.; Verhagen, W.I.; Wuyts, F.L.; Huygen, P.L.; D'Haese, P.; Robertson, N.G.; Morton, C.C.; McGuirt, W.T.; Smith, R.J.; Declau, F.; Van de Heyning, P.H.; Van Camp, G. High prevalence of symptoms of Meniere's disease in three families with a mutation in the COCH gene. Hum. Mol. Genet., 1999, 8, 1425-1429.
63. Doi, K.; Sato, T.; Kuramasu, T.; Hibino, H.; Kitahara, T.; Horii, A.; Matsushiro, N.; Fuse, Y.; Kubo, T. Meniere's disease is associated with single nucleotide polymorphisms in the human potassium channel genes, KCNE1 and KCNE3. ORL J. Otorhinolaryngol. Relat. Spec., 2005, 67(5), 289-293.
64. Koo, J.W.; Oh, S.H.; Chang, S.O.; Park, M.H.; Lim, M.J.; Yoo, T.J.; Kim, C.S. Association of HLA-DR and type II collagen autoimmunity with Meniere's disease. Tissue Antigens, 2003, 61(1), 99-103.
65. Lopez Escamez, J.A.; Vilchez, J.R.; Soto-Varela, A.; Santos-Perez, S.; Perez-Garrigues, H.; Aran, I.; Lopez-Nevot, M.A. HLADRB1* 1101 allele may be associated with bilateral Menierés disease in southern european population. Otol. Neurotol., 2007, 28(7), 891-895.
66. Teggi, R.; Lanzani, C.; Zagato, L.; Delli Carpini, S.; Manunta, P.; Bianchi, G.; Bussi, M. Gly460Trp alpha-adducin mutation as a possible mechanism leading to endolymphatic hydrops in Meniere's syndrome. Otol. Neurotol., 2008, 29(6), 824-828.
67. Kawaguchi, S.; Hagiwara, A.; Suzuki, M. Polymorphic analysis of the heat-shock protein 70 gene (HSPA1A) in Menière's disease. Acta Otolaryngol., 2008, 128(11), 1173-1177.
68. Lopez-Escamez, J.A.; Moreno, A.; Bernal, M.; Perez-Garrigues, H.; Santos-Perez, S.; Soto-Varela, A.; Aran, I.; Fernandez-Sanfrancisco, O.; Lopez-Nevot, A.; Lopez-Nevot, M.A. Poly (ADP- Ribose) Polymerase-1 (PARP-1) longer alleles spanning the promoter region may confer protection to Bilateral Menierés disease. Acta Otolaryngol., 2009, 129(11), 1222-1225.
69. Lopez-Escamez, J.A.; Saenz-Lopez, P.; Acosta, L.; Moreno, A.; Gazquez, I.; Perez-Garrigues, H.; Lopez-Nevot, A.; Lopez-Nevot, M.A. Association of a functional polymorphism of PTPN22 encoding a lymphoid protein phosphatase in bilateral Menierés disease. Laryngoscope, 2010, 120(1), 103-107.
70. Lopez-Escamez, J.A.; Saenz-Lopez, P.; Gazquez, I.; Moreno, A.; Gonzalez-Oller, C.; Soto-Varela, A.; Santos, S.; Aran, I.; Perez-Garrigues, H.; Ibañez, A.; Lopez-Nevot, M.A. Polymorphisms of CD16A and CD32 Fcgamma Receptors and Circulating Immunocomplexes in Meniere Disease: a case-control study. BMC Med. Genet., 2011, 12: 2.
71. Gazquez, I.; Lopez-Escamez, J.A.; Moreno, A.; Campbell, C.A.; Meyer, N.C.; Carey, J.P.; Minor, L.B.; Gantz, B.J.; Hansen, M.R.; Della Santina, C.; Aran, I.; Soto Varela, A.; Santos, S.; Batuecas, A.; Perez-Garrigues, H.; Lopez-Nevot, A.; Smith, R.J.H.; Lopez- Nevot, M.A. Functional variants in NOS1 and NOS2A are not associated with progressive hearing loss in Meniere's disease in an European Caucasian population. DNA Cell Biol., 2011, 30, PMID: 21612410.
72. Usami, S.; Takahashi, K.; Yuge, I.; Ohtsuka, A.; Namba, A.; Abe, S.; Fransen, E.; Patthy, L.; Otting, G.; Van Camp, G. Mutations in the COCH gene are a frequent cause of autosomal dominant progressive cochleo-vestibular dysfunction, but not of Meniere's disease. Eur. J. Hum. Genet., 2003, 11, 744-748.
73. Sanchez, E.; Lopez-Escamez, J.A.; Lopez-Nevot, M.A.; Lopez- Nevot, A.; Cortes, R.; Martin, J. Absence of COCH mutations in patients with Meniere disease. Eur. J. Hum. Genet., 2004, 12, 75-78.
74. Campbell, C.A.; Della Santina, C.C.; Meyer, N.C.; Smith, N.B.; Myrie, O.A.; Stone, E.M.; Fukushima, K.; Califano, J.; Carey, J.P.; Hansen, M.R.; Gantz, B.J.; Minor, L.B.; Smith, R.J. Polymorphisms in KCNE1 or KCNE3 are not associated with Ménière disease in the caucasian population. Am. J. Med. Genet. Part A, 2010, 152A, 67-74.
75. Schork, N.J.; Murray, S.S.; Frazer, K.A.; Topol, E.J. Common vs. rare allele hypotheses for complex diseases. Curr. Opin. Genet. Dev., 2009, 19(3), 212-219.
76. Wong, K.K.; deLeeuw, R.J.; Dosanjh, N.S.; Kimm, L.R.; Cheng, Z.; Horsman, D.E.; MacAulay, C.; Ng, R.T.; Brown, C.J.; Eichler, E.E.; Lam, W.L. A comprehensive analysis of common copynumber variations in the human genome. Am. J. Hum. Genet., 2007, 80(1), 91-104.